The annual American Society of Clinical Oncology Conference kicks off Friday, June 1, 2018.
Every year, thousands of healthcare professionals, scientists, and investors assemble in Chicago to hear about the latest scientific breakthroughs redefining cancer care. Over the course of this five-day conference, hundreds of companies -- including Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Loxo Oncology (NASDAQ:LOXO) -- will be providing much-anticipated pipeline updates and plenty of market-moving news.
Not in Chicago? No worries! The Motley Fool's healthcare team has got you covered with all the latest headlines, announcements, and analysis. Be sure to check back on this page for updates!
- ASCO Conference Preview: Here's What Biotech Investors Need to Watch
- The Big Thing to Watch at ASCO 2018
- Winners and Losers From the Biggest Cancer Meeting of the Year (So Far)
- Does a Blue Ribbon Make This Biotech Stock a Buy Now?
- Read This Before You Buy Immuno-Oncology Stocks
- Why ImmunoGen Jumped Higher Today
- #ASCO18: A Weekend of Surprises
- Why Data at ASCO 2018 Sent Immunomedics Shares Soaring Today
- Here's Why Genomic Health Rocketed Higher Today
- Could Celgene Shake Up the CAR-T Market?
- Why #ASCO18 Caused Blueprint Medicines Shares To Tumble Up to 16% Today
- ASCO 2018 Sends TG Therapeutics Stock Soaring 10% Today
- Is Nektar Therapeutics Stock a Bargain Now?
- 3 Reasons Amazing Isn't Good Enough for This Biotech Stock
Shannon Jones has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Bluebird Bio, Celgene, Genomic Health, and Gilead Sciences. The Motley Fool has a disclosure policy.